increas
express
proinflammatori
proangiogen
chemokin
contribut
ovarian
cancer
progress
induct
tumor
cell
prolifer
surviv
angiogenesi
metastasi
substanti
potenti
chemokin
facilit
progress
metastasi
ovarian
cancer
underscor
need
stringent
transcript
regul
review
highlight
key
mechan
regul
transcript
proinflammatori
chemokin
ovarian
cancer
cell
import
role
control
ovarian
cancer
progress
discuss
potenti
mechan
underli
increas
chemokin
express
drug
resist
along
perspect
futur
studi
chemokin
famili
cytokin
induc
chemotaxi
target
cell
though
origin
discov
abil
induc
leukocyt
migrat
infect
injur
site
recent
becam
clear
could
also
promot
cancer
progress
addit
induc
tumor
cell
prolifer
angiogenesi
metastasi
chemokin
receptor
regul
tumor
cell
differenti
surviv
current
human
chemokin
network
includ
open
access
known
chemokin
chemokin
receptor
base
number
space
conserv
ntermin
cystein
residu
form
disulfid
bond
chemokin
divid
four
group
x
c
cc
cxc
epitheli
ovarian
cancer
eoc
among
lead
caus
cancer
death
women
sinc
ovarian
cancer
relaps
becom
drugresist
surviv
rate
remain
low
progress
ovarian
cancer
oc
associ
increas
express
releas
proinflammatori
chemokin
contribut
ovarian
cancer
develop
induct
tumor
cell
prolifer
surviv
migrat
angiogenesi
chemokin
express
ovarian
cancer
cell
control
sever
level
includ
transcript
regul
posttranscript
regul
regul
mrna
stabil
translat
mechan
regul
cytokin
intracellular
storag
transport
releas
tabl
summar
chemokin
produc
ovarian
cancer
cell
sever
excel
review
address
physiolog
cellular
function
chemokin
ovarian
cancer
thu
review
focu
instead
main
mechan
regul
transcript
chemokin
ovarian
cancer
cell
chemokin
regul
transcript
level
bind
transcript
factor
repressor
gene
promot
enhanc
region
transcript
factor
control
express
inflammatori
chemokin
includ
nuclear
activ
signal
transduc
activ
transcript
stat
famili
activ
constitut
increas
aggress
ovarian
cancer
inhibit
signal
suppress
angiogenesi
tumorigen
ovarian
cancer
cell
increas
sensit
chemotherapi
apoptosi
underli
mechan
like
involv
chemokin
express
sinc
sever
studi
demonstr
express
mediat
ovarian
cancer
cell
increas
activ
ovarian
cancer
cell
mediat
enzym
kinas
ikk
complex
phosphoryl
inhibitori
protein
result
proteasom
degrad
nuclear
transloc
subunit
addit
phosphoryl
ikk
also
phosphoryl
subunit
particularli
cytoplasm
degrad
result
nuclear
transloc
subunit
repres
gener
step
activ
specif
respons
mediat
subunit
composit
complex
posttransl
modif
addit
transcript
factor
bind
promot
sequenc
chemokin
express
regul
epigenet
modif
includ
histon
modif
well
posttransl
modif
transcript
factor
particularli
subunit
believ
histon
acetyl
acetyl
transcript
factor
induc
histon
acetyl
transferas
hat
gener
promot
transcript
activ
hypoacetyl
induc
histon
deacetylas
hdac
activ
associ
transcript
repress
sinc
hypoacetyl
tumor
suppressor
gene
hdac
link
tumor
develop
hdac
inhibitor
evalu
therapeut
effect
cancer
includ
ovarian
cancer
clinic
studi
use
hdac
inhibitor
treatment
ovarian
cancer
summar
recent
eleg
review
khabel
numer
studi
shown
hdac
regul
chemokin
express
differ
cell
type
howev
role
regul
chemokin
express
ovarian
cancer
yet
document
ovarian
cancer
tissu
ascit
character
decreas
oxygen
content
stabil
transcript
factor
hypoxiainduc
respond
hypoxia
increas
transcript
gene
promot
surviv
lowoxygen
condit
thu
promot
angiogenesi
oncogenesi
inde
increas
express
detect
epitheli
ovarian
cancer
correl
poor
prognosi
hypoxia
induc
express
ovarian
cancer
cell
semin
studi
xu
et
al
demonstr
hypox
condit
increas
express
ovarian
cancer
cell
increas
bind
promot
mechan
hypoxia
increas
transcript
involv
activ
transform
growth
factor
betaactiv
kinas
result
increas
ikk
activ
recruit
promot
addit
hypoxia
induc
direct
bind
hypoxiarespons
element
hre
locat
next
bind
site
human
promot
result
increas
express
one
consequ
activ
increas
express
glycolyt
gene
result
increas
aerob
glycolysi
glucos
consumpt
lactic
acid
product
warburg
effect
high
rate
glucos
consumpt
lactic
acid
product
contribut
acidif
tumor
environ
cancer
progress
xu
et
al
show
acid
ph
increas
transcript
enhanc
bind
promot
ovarian
cancer
cell
addit
endotheli
cell
lactat
shown
activ
transcript
induc
degrad
role
lactat
metabolit
glycolyt
pathway
regul
proangiogen
chemokin
express
ovarian
cancer
cell
yet
investig
especi
sinc
recent
studi
indic
high
level
aerob
glycolysi
lactat
product
ovarian
tumor
hyperglycemia
obes
thought
contribut
factor
cancer
develop
progress
calor
restrict
associ
reduc
cancer
incid
reduc
calori
intak
exercis
bodi
switch
obtain
energi
fatti
acid
oxid
result
keton
bodi
product
intriguingli
recent
studi
shimazu
et
al
demonstr
keton
bodi
endogen
specif
inhibitor
hdac
administr
exogen
increas
histon
acetyl
correl
chang
transcript
sinc
hdac
regul
chemokin
transcript
deacetyl
histon
import
analyz
whether
hdac
inhibitor
regul
chemokin
express
ovarian
cancer
cell
whether
modul
metabol
state
grow
evid
increas
chemokin
express
tumor
cell
modul
cancer
develop
also
cancer
respons
resist
chemotherapi
major
contributor
acquir
chemoresist
ovarian
cancer
cell
increas
express
chemokin
induc
platinumbas
drug
carboplatin
cisplatin
mitot
inhibitor
docetaxel
paclitaxel
mechan
respons
increas
express
induc
paclitaxel
ovarian
cancer
cell
involv
increas
express
tolllik
receptor
tlr
increas
bind
promot
bortezomib
bz
first
fda
approv
proteasom
inhibitor
shown
limit
effect
ovarian
cancer
treatment
singl
agent
howev
bz
consid
combin
cisplatin
sinc
bz
prevent
cisplatininduc
degrad
cisplatin
influx
transport
result
enhanc
cisplatin
uptak
tumor
cell
kill
recent
shown
bz
increas
express
ovarian
cancer
cell
affect
express
gene
respons
mechan
involv
gene
specif
recruit
phosphoryl
promot
suggest
antiinflammatori
therapi
target
might
increas
bz
effect
ovarian
cancer
treatment
sinc
approxim
women
diagnos
ovarian
cancer
die
chemoresist
metastat
diseas
understand
molecular
mechan
chemotherapeut
intervent
increas
chemokin
express
ovarian
cancer
cell
lead
develop
effect
combin
strategi
chemokin
list
tabl
identifi
ovarian
cancer
cell
tissu
variou
onlin
databas
use
assess
put
transcript
factor
bind
site
review
obtain
chemokin
promot
sequenc
ncbi
databas
use
alggen
promotermap
program
search
transcript
factor
bind
site
found
put
bind
site
list
tabl
bind
site
experiment
confirm
highlight
bold
label
asterisk
limit
discuss
transcript
mechan
chemokin
experiment
confirm
ovarian
cancer
cell
first
insight
chemokin
transcript
regul
obtain
use
vitro
electrophoret
mobil
shift
assay
emsa
overexpress
experi
chromatin
immunoprecipit
chip
gener
provid
realist
pictur
transcript
factor
bind
endogen
promot
sequenc
live
cell
import
determin
macrophag
infiltr
ovarian
tumor
although
origin
thought
inhibitori
effect
ovarian
cancer
progress
recent
studi
indic
increas
invas
ovarian
cancer
cell
resist
chemotherapi
put
transcript
factor
bind
site
identifi
human
promot
list
tabl
experiment
studi
demonstr
bind
promot
oc
cell
figur
even
though
bind
site
locat
distal
regulatori
region
human
promot
figur
sever
studi
demonstr
involv
regul
express
oc
cell
addit
express
regul
recruit
transcript
factor
inhibit
activ
decreas
promot
recruit
express
interestingli
bind
site
human
promot
nucleotid
sequenc
site
human
promot
curious
increas
paclitaxel
bortezomib
indic
paclitaxel
bzinduc
increas
promot
specif
promot
cell
motil
invas
phosphoryl
tyrosin
residu
increas
transcript
activ
oc
cell
mcsf
induc
phosphoryl
activ
increas
express
addit
stat
transcript
factor
studi
cell
type
indic
express
posit
regul
though
transcript
factor
report
involv
neg
regul
oc
cell
studi
involv
cell
type
report
neg
regul
specif
homodim
transcript
factor
smrt
suggest
suppress
express
hepat
cell
adipocyt
contribut
ovarian
cancer
progress
induc
endotheli
epitheli
cell
prolifer
migrat
put
transcript
factor
bind
site
identifi
human
promot
list
tabl
experiment
studi
demonstr
bind
transcript
factor
ccaat
displac
protein
cdp
stimul
promot
human
cell
figur
ovarian
cancer
cell
though
gene
express
found
regul
mainli
pathway
specif
dna
bind
addit
posit
regul
studi
use
human
melanocyt
indic
express
neg
control
transcript
repressor
cdp
poli
adpribos
exact
mechan
cdp
inhibit
express
fulli
understood
howev
like
involv
displac
transactiv
factor
bind
promot
result
transcript
repress
put
transcript
factor
bind
site
identifi
human
promot
list
tabl
howev
experiment
studi
demonstr
bind
human
promot
figur
ovarian
cancer
cell
express
depend
addit
express
oc
cell
induc
tnf
inhibit
overexpress
tumor
suppressor
inflammatori
chemokin
origin
discov
neutrophil
chemoattract
induc
leukocytemedi
inflamm
contribut
cancer
progress
induct
tumor
cell
prolifer
migrat
angiogenesi
express
level
directli
correl
ovarian
cancer
progress
suppress
express
inhibit
angiogenesi
tumorigen
ovarian
cancer
cell
number
studi
identifi
minim
region
human
promot
span
nucleotid
necessari
transcript
contain
bind
site
ccaat
enhancerbind
protein
beta
cebp
factor
nrf
addit
transcript
ovarian
cancer
cell
posit
regul
transcript
factor
earli
growth
bind
promot
enzym
ikk
complex
phosphoryl
lead
cytoplasm
degrad
result
increas
transcript
activ
figur
crucial
express
regul
cell
type
bind
sequenc
ggaatttcc
locat
gene
cell
type
transcript
regul
predominantli
homodim
phosphoryl
serin
increas
transcript
activ
interact
transcript
factor
regul
decreas
affin
nuclear
recent
shown
ovarian
cancer
cell
transcript
regul
proteasom
inhibit
develop
strategi
inhibit
transcript
paradox
increas
express
ovarian
cancer
cell
increas
recruit
promot
adjac
site
promot
cebp
bind
site
figur
even
though
direct
involv
cebp
regul
ovarian
cancer
cell
yet
demonstr
upregul
express
hypoxia
ovarian
cancer
cell
well
document
transcript
also
regul
transcript
factor
consist
fo
fosb
jun
junb
subunit
activ
mediat
increas
express
hypoxia
paclitaxel
lysophosphatid
acid
lpa
treat
oc
cell
interestingli
recent
studi
shown
stress
hormon
norepinephrin
epinephrin
enhanc
express
fosbdepend
mechan
tabl
list
put
transcript
factor
bind
site
identifi
human
promot
although
studi
cell
type
shown
express
neg
regul
repress
factor
nrf
nuclear
receptor
corepressor
ncor
silenc
mediat
retino
acid
thyroid
hormon
receptor
smrt
hdac
potenti
involv
corepressor
oc
cell
yet
demonstr
consid
import
role
corepressor
play
regul
import
elucid
function
ovarian
cancer
set
continu
improv
understand
mechan
regul
chemokin
express
ovarian
cancer
cell
knowledg
contribut
develop
new
therapeut
strategi
target
increas
chemokin
express
chemoresist
metastat
ovarian
cancer
sever
import
question
remain
answer
specif
molecular
target
mechan
respons
chemokin
express
induc
chemotherapeut
drug
hypoxia
role
hdac
transcript
repressor
regul
chemokin
express
ovarian
cancer
cell
role
metabol
state
ovarian
cancer
cell
regul
chemokin
express
answer
question
may
open
new
avenu
therapeut
approach
treat
ovarian
cancer
